← Back to Search

Behavioral Intervention

Telehealth Group LIfestyle Balance for People with Stroke (tGLB-CVA) for Stroke (tGLB-CVA Trial)

N/A
Waitlist Available
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Body Mass Index ≥25
* All types of stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 6, 9, 12, 18 month
Awards & highlights

Summary

Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.

Who is the study for?
This trial is for individuals who have had a stroke or heart attack. Participants should be stable enough to engage in lifestyle changes via telehealth. Specific eligibility details are not provided, but typically, trials require participants to meet certain health criteria.
What is being tested?
The study is testing the effectiveness of a program called Group Lifestyle Balance (GLB-CVA), delivered through telehealth, for people who've had strokes. It's compared against waiting for 6 months without this intervention in a randomized controlled trial setup.
What are the potential side effects?
Since GLB-CVA involves lifestyle modifications delivered via telehealth, side effects may not be as prominent as drug interventions. However, any potential side effects are not detailed here and would depend on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 6, 9, 12, 18 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, 9, 12, 18 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Body Weight
Secondary study objectives
8-year Diabetes Risk
Behavioral Risk Factor Surveillance System (BRFSS)
Blood Glucose
+18 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telehealth Group LIfestyle Balance for People with Stroke (tGLB-CVA)Experimental Treatment1 Intervention
The telehealth Group Lifestyle Balance for People post stroke (tGLB-CVA) is a one-year program with 22 sessions. The tGLB-CVA is a modification of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) developed by the University of Pittsburgh Diabetes Prevention Support Center (DPSC). It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. The goal of the tGLB-CVA program is to help the participant achieve and maintain a 5-7% weight-loss through healthy eating and physical activity.
Group II: Wait List Control (WLC)Active Control1 Intervention
Participants randomized to the wait list control (WLC) will begin the telehealth Group Lifestyle Balance for People post stroke (tGLB-CVA) intervention 6 months after enrolling into the study and completing a baseline assessment.

Find a Location

Who is running the clinical trial?

National Institute on Disability, Independent Living, and Rehabilitation ResearchFED
74 Previous Clinical Trials
9,195 Total Patients Enrolled
7 Trials studying Stroke
2,337 Patients Enrolled for Stroke
Baylor Research InstituteLead Sponsor
202 Previous Clinical Trials
203,280 Total Patients Enrolled
6 Trials studying Stroke
285 Patients Enrolled for Stroke
~63 spots leftby Aug 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top